Stem cell impregnated nanofiber stent sleeve for on-stent production and intravascular delivery of paracrine factors

Chao Wei Hwang, Peter V. Johnston, Gary Gerstenblith, Robert G. Weiss, Gordon F. Tomaselli, Virginia E. Bogdan, Asmi Panigrahi, Aleksandra Leszczynska, Zhiyong Xia

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Stem cell therapies for atherosclerotic diseases are promising, but benefits remain modest with present cell delivery devices in part due to cell washout and immune attack. Many stem cell effects are believed mediated by paracrine factors (PFs) secreted by the stem cells which potentiate tissue repair via activation and enhancement of intrinsic host repair mechanisms We therefore sought to create an "intravascular paracrine factor factory" by harnessing stem cells on a stent using a nanofiber (NF) stent sleeve, and thus providing a sheltered milieu for cells to continuously produce PFs on-stent. The NF sleeve acts as a substrate on which stem cells grow, and as a semi-permeable barrier that protects cells from washout and host immune response while allowing free outward passage of PFs. NF stent sleeves were created by covering stents with electrospun poly-lactic-co-glycolic acid nanofibers and were then uniformly coated with mesenchymal stem cells (MSCs). NF sleeves blocked cell passage but did not hamper MSC attachment or proliferation, and did not alter MSC morphology or surface markers. NF sleeve MSCs continued to secrete PFs that were biologically active and successfully induced tubulogenesis in human endothelial cells. NF stent sleeves seeded with allogeneic MSCs implanted in pigs remained patent at 7 days without thrombotic occlusion or immune rejection. Our results demonstrate the feasibility of creating an intravascular PF factory using a stem cell impregnated NF stent sleeve, and pave the way for animal studies to assess the efficacy of local PF production to treat ischemic artery disease.

Original languageEnglish (US)
Pages (from-to)318-326
Number of pages9
JournalBiomaterials
Volume52
Issue number1
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Nanofibers
Stents
Stem cells
Stem Cells
Mesenchymal Stromal Cells
Industrial plants
Stem Cell Factor
Repair
Cell- and Tissue-Based Therapy
Endothelial cells
Swine
Endothelial Cells
Arteries
Equipment and Supplies
Animals
Chemical activation

Keywords

  • Coronary artery disease
  • Nanofiber
  • Paracrine factor
  • Peripheral artery disease
  • Stem cell

ASJC Scopus subject areas

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Stem cell impregnated nanofiber stent sleeve for on-stent production and intravascular delivery of paracrine factors. / Hwang, Chao Wei; Johnston, Peter V.; Gerstenblith, Gary; Weiss, Robert G.; Tomaselli, Gordon F.; Bogdan, Virginia E.; Panigrahi, Asmi; Leszczynska, Aleksandra; Xia, Zhiyong.

In: Biomaterials, Vol. 52, No. 1, 01.01.2015, p. 318-326.

Research output: Contribution to journalArticle

Hwang, CW, Johnston, PV, Gerstenblith, G, Weiss, RG, Tomaselli, GF, Bogdan, VE, Panigrahi, A, Leszczynska, A & Xia, Z 2015, 'Stem cell impregnated nanofiber stent sleeve for on-stent production and intravascular delivery of paracrine factors', Biomaterials, vol. 52, no. 1, pp. 318-326. https://doi.org/10.1016/j.biomaterials.2015.02.047
Hwang, Chao Wei ; Johnston, Peter V. ; Gerstenblith, Gary ; Weiss, Robert G. ; Tomaselli, Gordon F. ; Bogdan, Virginia E. ; Panigrahi, Asmi ; Leszczynska, Aleksandra ; Xia, Zhiyong. / Stem cell impregnated nanofiber stent sleeve for on-stent production and intravascular delivery of paracrine factors. In: Biomaterials. 2015 ; Vol. 52, No. 1. pp. 318-326.
@article{27e55ba36509424589cd9864717bea04,
title = "Stem cell impregnated nanofiber stent sleeve for on-stent production and intravascular delivery of paracrine factors",
abstract = "Stem cell therapies for atherosclerotic diseases are promising, but benefits remain modest with present cell delivery devices in part due to cell washout and immune attack. Many stem cell effects are believed mediated by paracrine factors (PFs) secreted by the stem cells which potentiate tissue repair via activation and enhancement of intrinsic host repair mechanisms We therefore sought to create an {"}intravascular paracrine factor factory{"} by harnessing stem cells on a stent using a nanofiber (NF) stent sleeve, and thus providing a sheltered milieu for cells to continuously produce PFs on-stent. The NF sleeve acts as a substrate on which stem cells grow, and as a semi-permeable barrier that protects cells from washout and host immune response while allowing free outward passage of PFs. NF stent sleeves were created by covering stents with electrospun poly-lactic-co-glycolic acid nanofibers and were then uniformly coated with mesenchymal stem cells (MSCs). NF sleeves blocked cell passage but did not hamper MSC attachment or proliferation, and did not alter MSC morphology or surface markers. NF sleeve MSCs continued to secrete PFs that were biologically active and successfully induced tubulogenesis in human endothelial cells. NF stent sleeves seeded with allogeneic MSCs implanted in pigs remained patent at 7 days without thrombotic occlusion or immune rejection. Our results demonstrate the feasibility of creating an intravascular PF factory using a stem cell impregnated NF stent sleeve, and pave the way for animal studies to assess the efficacy of local PF production to treat ischemic artery disease.",
keywords = "Coronary artery disease, Nanofiber, Paracrine factor, Peripheral artery disease, Stem cell",
author = "Hwang, {Chao Wei} and Johnston, {Peter V.} and Gary Gerstenblith and Weiss, {Robert G.} and Tomaselli, {Gordon F.} and Bogdan, {Virginia E.} and Asmi Panigrahi and Aleksandra Leszczynska and Zhiyong Xia",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.biomaterials.2015.02.047",
language = "English (US)",
volume = "52",
pages = "318--326",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Stem cell impregnated nanofiber stent sleeve for on-stent production and intravascular delivery of paracrine factors

AU - Hwang, Chao Wei

AU - Johnston, Peter V.

AU - Gerstenblith, Gary

AU - Weiss, Robert G.

AU - Tomaselli, Gordon F.

AU - Bogdan, Virginia E.

AU - Panigrahi, Asmi

AU - Leszczynska, Aleksandra

AU - Xia, Zhiyong

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Stem cell therapies for atherosclerotic diseases are promising, but benefits remain modest with present cell delivery devices in part due to cell washout and immune attack. Many stem cell effects are believed mediated by paracrine factors (PFs) secreted by the stem cells which potentiate tissue repair via activation and enhancement of intrinsic host repair mechanisms We therefore sought to create an "intravascular paracrine factor factory" by harnessing stem cells on a stent using a nanofiber (NF) stent sleeve, and thus providing a sheltered milieu for cells to continuously produce PFs on-stent. The NF sleeve acts as a substrate on which stem cells grow, and as a semi-permeable barrier that protects cells from washout and host immune response while allowing free outward passage of PFs. NF stent sleeves were created by covering stents with electrospun poly-lactic-co-glycolic acid nanofibers and were then uniformly coated with mesenchymal stem cells (MSCs). NF sleeves blocked cell passage but did not hamper MSC attachment or proliferation, and did not alter MSC morphology or surface markers. NF sleeve MSCs continued to secrete PFs that were biologically active and successfully induced tubulogenesis in human endothelial cells. NF stent sleeves seeded with allogeneic MSCs implanted in pigs remained patent at 7 days without thrombotic occlusion or immune rejection. Our results demonstrate the feasibility of creating an intravascular PF factory using a stem cell impregnated NF stent sleeve, and pave the way for animal studies to assess the efficacy of local PF production to treat ischemic artery disease.

AB - Stem cell therapies for atherosclerotic diseases are promising, but benefits remain modest with present cell delivery devices in part due to cell washout and immune attack. Many stem cell effects are believed mediated by paracrine factors (PFs) secreted by the stem cells which potentiate tissue repair via activation and enhancement of intrinsic host repair mechanisms We therefore sought to create an "intravascular paracrine factor factory" by harnessing stem cells on a stent using a nanofiber (NF) stent sleeve, and thus providing a sheltered milieu for cells to continuously produce PFs on-stent. The NF sleeve acts as a substrate on which stem cells grow, and as a semi-permeable barrier that protects cells from washout and host immune response while allowing free outward passage of PFs. NF stent sleeves were created by covering stents with electrospun poly-lactic-co-glycolic acid nanofibers and were then uniformly coated with mesenchymal stem cells (MSCs). NF sleeves blocked cell passage but did not hamper MSC attachment or proliferation, and did not alter MSC morphology or surface markers. NF sleeve MSCs continued to secrete PFs that were biologically active and successfully induced tubulogenesis in human endothelial cells. NF stent sleeves seeded with allogeneic MSCs implanted in pigs remained patent at 7 days without thrombotic occlusion or immune rejection. Our results demonstrate the feasibility of creating an intravascular PF factory using a stem cell impregnated NF stent sleeve, and pave the way for animal studies to assess the efficacy of local PF production to treat ischemic artery disease.

KW - Coronary artery disease

KW - Nanofiber

KW - Paracrine factor

KW - Peripheral artery disease

KW - Stem cell

UR - http://www.scopus.com/inward/record.url?scp=84932618549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932618549&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2015.02.047

DO - 10.1016/j.biomaterials.2015.02.047

M3 - Article

C2 - 25818438

AN - SCOPUS:84932618549

VL - 52

SP - 318

EP - 326

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 1

ER -